New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aeterna Zentaris Inc.
AEZS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

18M

Biotechnology

Next Earning date - 07 Nov 2024

18M

Biotechnology

Next Earning date - 07 Nov 2024

5.72USD
Shape0.12 ( 2.14%)
favorite-chart

Relative Strenght

90
favorite-chart

Volume Buzz

24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M % 3M -33.83 % 1Y -43.93 %

Key Metrics

Shape
  • Market Cap

    17.51M


  • Shares Outstanding

    3.06M


  • Share in Float

    1.20M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    5.72


  • Average Volume

    6037


  • Beta

    2.257


  • Range

    0.15-9.322033


  • Industry

    Biotechnology


  • Website

    https://www.zentaris.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.37x

P/S Ratio

0.13x

P/B Ratio

0.0

Debt/Equity

-764.7%

Net Margin

$-2.3

EPS

How AEZS compares to sector?

P/E Ratio

Relative Strength

Shape

AEZS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape107882%

2024-Revenue

$13.48

Shape29%

2024-EPS

$4M

Shape29%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.87
vs -0.50

Q3.22

arrow
arrow

N/A

-0.70
vs -0.25

Q4.22

arrow
arrow

N/A

-0.84
vs -0.50

Q1.23

arrow
arrow

N/A

-0.88
vs -0.50

Q2.23

arrow
arrow

N/A

-0.52
vs -0.87

Q3.23

arrow
arrow

N/A

-0.85
vs -0.70

Q4.23

arrow
arrow

N/A

-4.64
vs -0.84

Q1.24

arrow
arrow

N/A

-4.74
vs -0.88

Q2.24

arrow
arrow

N/A

-3.28
vs -0.52

Q3.24

arrow
arrow

N/A

-3.48
vs -0.85

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-137%

-222000.00  vs 599K

Q3.22

arrow
arrow

+209%

1.9M  vs 602K

Q4.22

arrow
arrow

+160%

2.5M  vs 956K

Q1.23

arrow
arrow

+40%

2.1M  vs 1.5M

Q2.23

arrow
arrow

+1112%

2.2M  vs -222000

Q3.23

arrow
arrow

-100%

3K  vs 1.9M

Q4.23

arrow
arrow

-95%

124.3K  vs 2.5M

Q1.24

arrow
arrow

-100%

4K  vs 2.1M

Q2.24

arrow
arrow

-51%

1.1M  vs 2.2M

Q3.24

arrow
arrow

+36567%

1.1M  vs 3K

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-8%

-0.08
vs -0.05

Q3.22

arrow
arrow

-6%

-0.06
vs -0.08

Q4.22

arrow
arrow

-58%

-0.58
vs -0.06

Q1.23

arrow
arrow

-14%

-0.14
vs -0.58

Q2.23

arrow
arrow

-9%

-0.09
vs -0.14

Q3.23

arrow
arrow

-16%

-0.16
vs -0.09

Q4.23

arrow
arrow

-32%

-0.32
vs -0.16

Q1.24

arrow
arrow

-44%

-0.44
vs -0.32

Institutionnal OwnershipShape

status-upQoQ

Q3.20

arrow
arrow

15

15
vs 16

-6%

Q4.20

arrow
arrow

15

15
vs 15

NA

Q1.21

arrow
arrow

39

39
vs 15

160%

Q2.21

arrow
arrow

38

38
vs 39

-3%

Q3.21

arrow
arrow

33

33
vs 38

-13%

Q4.21

arrow
arrow

31

31
vs 33

-6%

Q1.22

arrow
arrow

25

25
vs 31

-19%

Q2.22

arrow
arrow

31

31
vs 25

24%

Earnings Growth

Latest News